Behind the Paper: The High Financial Cost of Taking "Too Many" Medicines in Nigeria
Published in Pharmacy & Pharmacology, Public Health, and Economics
When a patient walks into a clinic, receiving a prescription is supposed to be the first step toward healing. But what happens when that single visit ends with a prescription for five, eight, or more than ten different drugs at once? In low- and middle-income countries like Nigeria, where health insurance covers only a fraction of the population and healthcare is paid almost entirely out-of-pocket, taking multiple medications can transform a routine health check into a devastating financial crisis.
Our team set out to investigate this precise dilemma at Offa Specialist Hospital in Kwara State, Nigeria. We wanted to know: how widespread is polypharmacy in a secondary healthcare setting, and what does it actually cost the patients on the receiving end?
The Dual Realities: Prescription Records vs. Daily Survival
To get the full story, we combined two research perspectives: a retrospective review of 2,000 prescriptions and a prospective survey of 100 patients and 50 healthcare professionals.
The Scale of the Problem: Over 37% of reviewed prescriptions met the criteria for polypharmacy (5 or more medications), with 12% involving "excessive polypharmacy" of 10 or more drugs. The average prescription contained 4.8 drugs.
The Cost Barrier: Among surveyed patients, 37% spent over ₦20,000 per month on drugs, with an average expenditure of ₦18,600. For 79% of patients, these costs represented a major financial burden.
Dangerous Compromises: High costs forced 66% of patients to skip doses, reduce medication intake, or delay purchases. Additionally, 78% depended on financial help from family and friends just to pay for their prescriptions.
Bridging the Gap: What Healthcare Providers See
The study revealed an overwhelming consensus among clinicians. Every single healthcare provider surveyed (100%) agreed that polypharmacy drives up treatment costs, and 84% noted that they frequently care for patients taking five or more medications. Crucially, 72% of providers recognized that some prescribed medications could be safely reduced through structured medication reviews.
Our findings underline an urgent need to rethink prescribing habits. Addressing polypharmacy isn't just a clinical goal to avoid adverse drug interactions—it is an economic lifeline for patients navigating out-of-pocket healthcare. Integrating routine medication reviews, strengthening clinical pharmacology collaboration, and expanding universal health coverage are critical steps to ensuring that treating an illness doesn't cause a financial crisis.
For Full Details visit, https://rdcu.be/fCwW2
Health ROI Architect, BioPolicy Strategist, Pharma Economic Futurist and Therapeutics Pioneer
Follow the Topic
-
BMC Health Services Research
An open access, peer-reviewed journal that considers articles on all aspects of health services research, focusing on digital health, governance, policy, system quality and safety, delivery and access, financing and economics, implementing reform, and the workforce.
Related Collections
With Collections, you can get published faster and increase your visibility.
Patients' knowledge of the indications for their medications
BMC Health Services Research is calling for submissions to our Collection on Patients' knowledge of the indications for their medications.
Understanding the indications for prescribed medications is crucial for patient safety and effective healthcare delivery. Many patients lack adequate knowledge about their medications, which can lead to non-adherence, adverse drug reactions, and suboptimal health outcomes. This Collection invites research that examines the extent of patients' medication knowledge, the factors influencing their understanding, and the implications for healthcare practice. By exploring these aspects, we aim to illuminate the gaps in medication literacy and the importance of patient engagement in their treatment regimens.
Enhancing patients' knowledge of their medications is vital for fostering informed decision-making and promoting adherence to treatment plans. Recent advances in medication counseling, patient education programs, and digital health technologies have shown promise in improving medication awareness. These interventions not only empower patients but also support healthcare providers in delivering personalized care. By fostering a culture of medication literacy, healthcare systems can enhance patient outcomes and reduce the burden of medication-related issues.
Topics for submission:
Assessing medication literacy in diverse populations
Barriers and facilitators to understanding medication indications
Impact of patient education and other related interventions on medication adherence
Tools, interventions and strategies for enhancing patient medication knowledge
Understand how, why for whom and under what circumstances interventions to enhance medication knowledge work or not
This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Sep 30, 2026
Promise, perception, and practice: workforce capability and technology integration in healthcare
BMC Health Services Research invites submissions on how health workforce professionals interact with, adopt, and shape the implementation of digital health technologies, artificial intelligence (AI), and modern electronic health record (EHR) systems. Whether these technologies deliver value depends not only on the technical specifications but also on how they are implemented, governed, evaluated, and continuously refined within the organizations and workforces in which they operate. Health systems worldwide are committing to technology portfolios at a pace that consistently outstrips the evidence base needed to guide them, leaving technology program leaders without the knowledge they need to make sound investment and deployment decisions. We particularly welcome work that bridges implementation science, clinical informatics, and health services research to generate evidence actionable for health systems managing growing technology portfolios.
Topics of interest include, but are not limited to:
- Adoption and sustained use: digital literacy, training, and effective human–AI collaboration
- Front-line feedback as a signal for monitoring and improving technology performance
- Case studies of AI tools (clinical systems, ambient documentation, EHRs, decision support) with focus on long-term value and sustainment
- Governance, evaluation frameworks, and learning health system models for continuous assessment
- Impacts on care quality, clinician well-being, efficiency, and costs, including unintended effects (e.g., workflow disruption, alert fatigue)
- Ethical, equity, and policy considerations, including evolving AI governance
- Innovative measurement using EHR logs, administrative data, and observational methods
- Development of standardized evaluation frameworks applicable across technologies and settings
We welcome submissions across all article types accepted by BMC Health Services Research, including research articles, systematic reviews, study protocols, database and software articles.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jan 29, 2027
